Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death

References

• Romero R, Copel J A, Hobbins J C. Intrauterine fetal demise and hemostatic failure: the fetal death syndrome. Clin Obstet Gynecol 1985; 28: 24–31
   PubMed Web of Science ®Google Scholar
• Weiner A E, Reid D E, Roby C C, Diamond L K. Coagulation defects with intrauterine death from Rh isosensitization. Am J Obstet Gynecol 1950; 60: 1015–1022
   PubMed Web of Science ®Google Scholar
• Reid D E, Weiner A E, Roby C C, Diamond L K. Maternal afibrinogenemia associated with long-standing intrauterine fetal death. Am J Obstet Gynecol 1953; 66: 500–506
   PubMed Web of Science ®Google Scholar
• Pritchard J A, Ratnoff O D. Studies of fibrinogen and other hemostatic factors in women with intrauterine death and delayed delivery. Surg Gynecol Obstet 1955; 101: 467–477
   PubMedGoogle Scholar
• Tricomi V, Kohl S G. [Fetal death in utero.]. Am J Obstet Gynecol 1957; 74: 1092–1097
   PubMed Web of Science ®Google Scholar
• Pritchard J A. Fetal death in utero. Obstet Gynecol 1959; 14: 573–580
   PubMed Web of Science ®Google Scholar
• de Boer K, ten Cate J W, Sturk A, Borm J J, Treffers P E. Enhanced thrombin generation in normal and hypertensive pregnancy. Am J Obstet Gynecol 1989; 160: 95–100
   PubMed Web of Science ®Google Scholar
• Yuen P M, Yin J A, Lao T T. Fibrinopeptide A levels in maternal and newborn plasma. Eur J Obstet Gynecol Reprod Biol 1989; 30: 239–244
   PubMed Web of Science ®Google Scholar
• Sorensen J D, Secher N J, Jespersen J. Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. A possible link to placental function. Acta Obstet Gynecol Scand 1995; 74: 257–261
   PubMed Web of Science ®Google Scholar
• Walker M C, Garner P R, Keely E J, Rock G A, Reis M D. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997; 177: 162–169
   PubMed Web of Science ®Google Scholar
• Bellart J, Gilabert R, Miralles R M, Monasterio J, Cabero L. Endothelial cell markers and fibrinopeptide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998; 46: 17–21
   PubMed Web of Science ®Google Scholar
• Lockwood C J, Krikun G, Schatz F. The decidua regulates hemostasis in human endometrium. Semin Reprod Endocrinol 1999; 17: 45–51
   PubMedGoogle Scholar
• Lockwood C J, Krikun G, Schatz F. Decidual cell-expressed tissue factor maintains hemostasis in human endometrium. Ann N.Y Acad Sci 2001; 943: 77–88
   PubMed Web of Science ®Google Scholar
• Kuczynski J, Uszynski W, Zekanowska E, Soszka T, Uszynski M. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in the placenta and myometrium. Eur J Obstet Gynecol Reprod Biol 2002; 105: 15–19
   PubMed Web of Science ®Google Scholar
• Erlich J, Parry G C, Fearns C, Muller M, Carmeliet P, Luther T, Mackman N. Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation. Proc Natl Acad Sci U.S.A 1999; 96: 8138–8143
   PubMed Web of Science ®Google Scholar
• Creter D. Amnioplastin: new reagent for coagulation tests. Lancet 1977; 2: 251
   PubMed Web of Science ®Google Scholar
• Omsjo I H, Oian P, Maltau J M, Osterud B. Thromboplastin activity in amniotic fluid. Gynecol Obstet Invest 1985; 19: 1–5
   PubMed Web of Science ®Google Scholar
• Lockwood C J, Bach R, Guha A, Zhou X D, Miller W A, Nemerson Y. Amniotic fluid contains tissue factor, a potent initiator of coagulation. Am J Obstet Gynecol 1991; 165: 1335–1341
   PubMed Web of Science ®Google Scholar
• Uszynski M, Zekanowska E, Uszynski W, Kuczynski J. Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism. Eur J Obstet Gynecol Reprod Biol 2001; 95: 163–166
   PubMed Web of Science ®Google Scholar
• Holmes V A, Wallace J M. Haemostasis in normal pregnancy: a balancing act?. Biochem Soc Trans 2005; 33: 428–432
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Espinoza J, Yoshimatsu J, Kim Y M, Bujold E, Edwin S, Yoon B H, Romero R. Activation of coagulation system in preterm labor and preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2002; 11: 368–373
   PubMedGoogle Scholar
• Reinthaller A, Mursch-Edlmayr G, Tatra G. Thrombin-antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. Br J Obstet Gynaecol 1990; 97: 506–510
   PubMedGoogle Scholar
• Uszynski M. Generation of thrombin in blood plasma of non-pregnant and pregnant women studied through concentration of thrombin-antithrombin III complexes. Eur J Obstet Gynecol Reprod Biol 1997; 75: 127–131
   PubMed Web of Science ®Google Scholar
• Reber G, Amiral J, de M P. Modified antithrombin III levels during normal pregnancy and relationship with prothrombin fragment F1 + 2 and thrombin-antithrombin complexes. Thromb Res 1998; 91: 45–47
   PubMed Web of Science ®Google Scholar
• Andersson T, Lorentzen B, Hogdahl H, Clausen T, Mowinckel M C, Abildgaard U. Thrombin-inhibitor complexes in the blood during and after delivery. Thromb Res 1996; 82: 109–117
   PubMed Web of Science ®Google Scholar
• VanWijk M J, Boer K, Berckmans R J, Meijers J C, van der Post J A, Sturk A, Vanbavel E, Nieuwland R. Enhanced coagulation activation in preeclampsia: the role of APC resistance, microparticles and other plasma constituents. Thromb Haemost 2002; 88: 415–420
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Sumimoto K, Tokunaga N, Sugimura M, Nishiguchi T, Kanayama N, Terao T. Coagulation index to distinguish severe preeclampsia from normal pregnancy. Semin Thromb Hemost 2002; 28: 495–500
   PubMed Web of Science ®Google Scholar
• Hayashi M, Numaguchi M, Ohkubo N, Yaoi Y. Blood macrophage colony-stimulating factor and thrombin-antithrombin III complex concentrations in pregnancy and preeclampsia. Am J Med Sci 1998; 315: 251–257
   PubMed Web of Science ®Google Scholar
• Hayashi M, Inoue T, Hoshimoto K, Negishi H, Ohkura T, Inaba N. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia. Eur J Haematol 2002; 69: 297–302
   PubMed Web of Science ®Google Scholar
• Chaiworapongsa T, Yoshimatsu J, Espinoza J, Kim Y M, Berman S, Edwin S, Yoon B H, Romero R. Evidence of in vivo generation of thrombin in patients with small-for-gestational-age fetuses and pre-eclampsia. J Matern Fetal Neonatal Med 2002; 11: 362–367
   PubMedGoogle Scholar
• Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers. Gynecol Obstet Invest 1987; 24: 170–178
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Tokunaga N, Sugimura M, Suzuki K, Kanayama N, Nishiguchi T, Terao T. Coagulation/fibrinolysis disorder in patients with severe preeclampsia. Semin Thromb Hemost 1999; 25: 451–454
   PubMed Web of Science ®Google Scholar
• Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset P M, Wisloff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999; 78: 191–197
   PubMed Web of Science ®Google Scholar
• Hayashi M, Ohkura T. Elevated levels of serum macrophage colony-stimulating factor in normotensive pregnancies complicated by intrauterine fetal growth restriction. Exp Hematol 2002; 30: 388–393
   PubMed Web of Science ®Google Scholar
• Ballard H S, Marcus A J. Primary and secondary platelet aggregation in uraemia. Scand J Haematol 1972; 9: 198–203
   PubMedGoogle Scholar
• Elovitz M A, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 2001; 185: 1059–1063
   PubMed Web of Science ®Google Scholar
• Rosen T, Kuczynski E, O'Neill L M, Funai E F, Lockwood C J. Plasma levels of thrombin-antithrombin complexes predict preterm premature rupture of the fetal membranes. J Matern Fetal Med 2001; 10: 297–300
   PubMedGoogle Scholar
• Gonzalez R P, Gomez R M, Castro R S, Nien J K, Merino P O, Etchegaray A B, Carstens M R, Medina L H, Viviani P G, Rojas I T. [A national birth weight distribution curve according to gestational age in chile from 1993 to 2000]. Rev Med Chil 2004; 132: 1155–1165
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99: 159–167
   PubMed Web of Science ®Google Scholar
• Taylor F B, Jr, Toh C H, Hoots W K, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86: 1327–1330
   PubMed Web of Science ®Google Scholar
• Toh C H, Hoots W K. The scoring system of the Scientific and Standardisation Committee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis: a 5-year overview. J Thromb Haemost 2007; 5: 604–606
   PubMed Web of Science ®Google Scholar
• Redline R W, Heller D, Keating S, Kingdom J. Placental diagnostic criteria and clinical correlation–a workshop report. Placenta 2005; 26(Suppl A)S114–S117
   PubMed Web of Science ®Google Scholar
• Patel J V, Lim H S, Nadar S, Tayebjee M, Hughes E A, Lip G Y. Abnormal soluble CD40 ligand and C-reactive protein concentrations in hypertension: relationship to indices of angiogenesis. J Hypertens 2006; 24: 117–121
   PubMed Web of Science ®Google Scholar
• Lip G Y, Patel J V, Hughes E, Hart R G. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 2007; 38: 1229–1237
   PubMed Web of Science ®Google Scholar
• Hermann A, Rauch B H, Braun M, Schror K, Weber A A. Platelet CD40 ligand (CD40L)–subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001; 12: 74–82
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Varghese S, Vitseva O, Tanriverdi K, Freedman J E. CD40 ligand influences platelet release of reactive oxygen intermediates. Arterioscler Thromb Vasc Biol 2005; 25: 2428–2434
   PubMed Web of Science ®Google Scholar
• Henn V, Slupsky J R, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek R A. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998; 391: 591–594
   PubMed Web of Science ®Google Scholar
• Henn V, Steinbach S, Buchner K, Presek P, Kroczek R A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047–1054
   PubMed Web of Science ®Google Scholar
• Saleh A A, Bottoms S F, Farag A M, Dombrowski M P, Welch R A, Norman G, Mammen E F. Markers for endothelial injury, clotting and platelet activation in preeclampsia. Arch Gynecol Obstet 1992; 251: 105–110
   PubMed Web of Science ®Google Scholar
• Leiberman J R, Hagay Z J, Mazor M, Aharon M, Nathan I, Dvilansky A. Plasma and urine beta-thromboglobulin in severe preeclampsia. Arch Gynecol Obstet 1988; 243: 165–168
   PubMed Web of Science ®Google Scholar
• Holthe M R, Lyberg T, Staff A C, Berge L N. Leukocyte-platelet interaction in pregnancies complicated with preeclampsia. Platelets 2005; 16: 91–97
   PubMed Web of Science ®Google Scholar
• Lok C A, Nieuwland R, Sturk A, Hau C M, Boer K, Vanbavel E, Vanderpost J A. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets 2007; 18: 68–72
   PubMed Web of Science ®Google Scholar
• Tomer A. Platelet activation as a marker for in vivo prothrombotic activity: detection by flow cytometry. J Biol Regul Homeost Agents 2004; 18: 172–177
   PubMed Web of Science ®Google Scholar
• Yoneyama Y, Suzuki S, Sawa R, Kiyokawa Y, Power G G, Araki T. Plasma adenosine levels and P-selectin expression on platelets in preeclampsia. Obstet Gynecol 2001; 97: 366–370
   PubMed Web of Science ®Google Scholar
• Bar J, Zosmer A, Hod M, Elder M G, Sullivan M H. The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. Thromb Haemost 1997; 78: 1255–1261
   PubMed Web of Science ®Google Scholar
• Bagamery K, Landau R, Kvell K, Graham J. Different platelet activation levels in non-pregnant, normotensive pregnant, pregnancy-induced hypertensive and pre-eclamptic women. A pilot study of flow cytometric analysis. Eur J Obstet Gynecol Reprod Biol 2005; 121: 117–118
   PubMed Web of Science ®Google Scholar
• Harlow F H, Brown M A, Brighton T A, Smith S L, Trickett A E, Kwan Y L, Davis G K. Platelet activation in the hypertensive disorders of pregnancy. Am J Obstet Gynecol 2002; 187: 688–695
   PubMed Web of Science ®Google Scholar
• Missfelder-Lobos H, Teran E, Lees C, Albaiges G, Nicolaides K H. Platelet changes and subsequent development of pre-eclampsia and fetal growth restriction in women with abnormal uterine artery Doppler screening. Ultrasound Obstet Gynecol 2002; 19: 443–448
   PubMed Web of Science ®Google Scholar
• Felfernig-Boehm D, Salat A, Vogl S E, Murabito M, Felfernig M, Schmidt D, Mittlboeck M, Husslein P, Mueller M R. Early detection of preeclampsia by determination of platelet aggregability. Thromb Res 2000; 98: 139–146
   PubMed Web of Science ®Google Scholar
• Myatt L, Miodovnik M. Prediction of preeclampsia. Semin Perinatol 1999; 23: 45–57
   PubMed Web of Science ®Google Scholar
• Konijnenberg A, van der Post J A, Mol B W, Schaap M C, Lazarov R, Bleker O P, Boer K, Sturk A. Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia? A prospective study. Am J Obstet Gynecol 1997; 177: 434–442
   PubMed Web of Science ®Google Scholar
• Bodis J, Torok A, Tinneberg H R. Hypothesis of preeclampsia requires inclusion of the role of platelets. Am J Obstet Gynecol 1997; 177: 243–244
   PubMed Web of Science ®Google Scholar
• Konijnenberg A, Stokkers E W, van der Post J A, Schaap M C, Boer K, Bleker O P, Sturk A. Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules. Am J Obstet Gynecol 1997; 176: 461–469
   PubMed Web of Science ®Google Scholar
• Ahlawat S, Pati H P, Bhatla N, Fatima L, Mittal S. Plasma platelet aggregating factor and platelet aggregation studies in pre-eclampsia. Acta Obstet Gynecol Scand 1996; 75: 428–431
   PubMed Web of Science ®Google Scholar
• Halim A, Kanayama N, el M E, Nakashima A, Bhuiyan A B, Khatun S, Terao T. Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significances. Am J Obstet Gynecol 1996; 174: 272–277
   PubMed Web of Science ®Google Scholar
• Janes S L, Kyle P M, Redman C, Goodall A H. Flow cytometric detection of activated platelets in pregnant women prior to the development of pre-eclampsia. Thromb Haemost 1995; 74: 1059–1063
   PubMed Web of Science ®Google Scholar
• Janes S L, Goodall A H. Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy. Clin Sci (Lond) 1994; 86: 731–739
   PubMed Web of Science ®Google Scholar
• Hutt R, Ogunniyi S O, Sullivan M H, Elder M G. Increased platelet volume and aggregation precede the onset of preeclampsia. Obstet Gynecol 1994; 83: 146–149
   PubMed Web of Science ®Google Scholar
• Norris L A, Gleeson N, Sheppard B L, Bonnar J. Whole blood platelet aggregation in moderate and severe pre-eclampsia. Br J Obstet Gynaecol 1993; 100: 684–688
   PubMedGoogle Scholar
• Louden K A, Broughton P F, Heptinstall S, Fox S C, Mitchell J R, Symonds E M. Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol 1991; 98: 1239–1244
   PubMedGoogle Scholar
• Pekonen F, Rasi V, Ammala M, Viinikka L, Ylikorkala O. Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 1986; 43: 553–560
   PubMed Web of Science ®Google Scholar
• Romero R, Snyder E, Scott D, Oyarzun E, Hobbins J C, Duffy T P. Beta-thromboglobulin during normal pregnancy, labor, and puerperium. Am J Perinatol 1988; 5: 109–112
   PubMed Web of Science ®Google Scholar
• Hagay Z J, Leiberman J R, Mazor M, Aharon M, Dvilansky A. [Plasma and urinary beta-thromboglobulin as indicators of platelet activation in pre-eclampsia]. Harefuah 1988; 114: 427–429
   PubMedGoogle Scholar
• Karalis I, Nadar S K, Al Y E, Blann A D, Lip G Y. Platelet activation in pregnancy-induced hypertension. Thromb Res 2005; 116: 377–383
   PubMed Web of Science ®Google Scholar
• Yoneyama Y, Suzuki S, Sawa R, Miura A, Doi D, Otsubo Y, Araki T. Plasma nitric oxide levels and the expression of P-selectin on platelets in preeclampsia. Am J Obstet Gynecol 2002; 187: 676–680
   PubMed Web of Science ®Google Scholar
• Erez O, Hallak M, Luber A, Maymon E, Mazor M, Tomer A. Platelets Activation Marker as Predictor of Severe Preeclampsia in Patients with History of Preeclampsia. Am J Obstet Gynecol 2001; 185: S175
   Web of Science ®Google Scholar
• Ballegeer V C, Spitz B, De Baene L A, Van Assche A F, Hidajat M, Criel A M. Platelet activation and vascular damage in gestational hypertension. Am J Obstet Gynecol 1992; 166: 629–633
   PubMed Web of Science ®Google Scholar
• Ayhan A, Akkok E, Urman B, Yarali H, Dundar S, Kirazli S. Beta-thromboglobulin and platelet factor 4 levels in pregnancy and preeclampsia. Gynecol Obstet Invest 1990; 30: 12–14
   PubMed Web of Science ®Google Scholar
• Csaicsich P, Deutinger J, Tatra G. Platelet specific proteins (beta-thromboglobulin and platelet factor 4) in normal pregnancy and in pregnancy complicated by preeclampsia. Arch Gynecol Obstet 1989; 244: 91–95
   PubMed Web of Science ®Google Scholar
• Socol M L, Weiner C P, Louis G, Rehnberg K, Rossi E C. Platelet activation in preeclampsia. Am J Obstet Gynecol 1985; 151: 494–497
   PubMed Web of Science ®Google Scholar
• Arocha-Pinango C L, Ojeda A, Lopez G, Garcia L, Linares J. beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in obstetrical cases. Acta Obstet Gynecol Scand 1985; 64: 115–120
   PubMed Web of Science ®Google Scholar
• Alacacioglu I, Ozcan M A, Piskin O, Yuksel F, Alacacioglu A, Demirkan F, Ozsan H G, Polat M, Ozgenc Y, Undar B. Increased concentration of soluble CD40 ligand in preeclampsia. Clin Appl Thromb Hemost 2007; 13: 201–205
   PubMed Web of Science ®Google Scholar
• Laskowska M, Laskowska K, Leszczynska-Gorzelak B, Oleszczuk J. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation. Gynecol Obstet Invest 2007; 64: 8–13
   PubMed Web of Science ®Google Scholar
• Mellembakken J R, Solum N O, Ueland T, Videm V, Aukrust P. Increased concentrations of soluble CD40 ligand, RANTES and GRO-alpha in preeclampsia–possible role of platelet activation. Thromb Haemost 2001; 86: 1272–1276
   PubMed Web of Science ®Google Scholar
• Oron G, Ben-Haroush A, Hod M, Orvieto R, Bar J. Serum-soluble CD40 ligand in normal pregnancy and in preeclampsia. Obstet Gynecol 2006; 107: 896–900
   PubMed Web of Science ®Google Scholar
• Erez O, Romero R, Hoppensteadt D, Fareed J, Chaiworapongsa T, Kusanovic J P, Mazaki-Tovi S, Gotsch F, Than N G, Vaisbuch E, et al. Premature labor: a state of platelet activation?. J Perinat Med 2008; 36: 377–387
   PubMed Web of Science ®Google Scholar
• Holvoet P, Collen D. Thrombosis and atherosclerosis. Curr Opin Lipidol 1997; 8: 320–328
   PubMed Web of Science ®Google Scholar
• Dimitrow P P, Undas A, Bober M, Tracz W, Dubiel J S. Obstructive hypertrophic cardiomyopathy is associated with enhanced thrombin generation and platelet activation. Heart 2008; 94: e21
   Web of Science ®Google Scholar
• Maroney S A, Haberichter S L, Friese P, Collins M L, Ferrel J P, Dale G L, Mast A E. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood 2007; 109: 1931–1937
   PubMed Web of Science ®Google Scholar
• Sobocka M B, Sobocki T, Babinska A, Hartwig J H, Li M, Ehrlich Y H, Kornecki E. Signaling pathways of the F11 receptor (F11R; a.k.a. JAM-1, JAM-A) in human platelets: F11R dimerization, phosphorylation and complex formation with the integrin GPIIIa. J Recept Signal Transduct Res 2004; 24: 85–105
   PubMed Web of Science ®Google Scholar
• Weiss H J, Lages B. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity–a comparison with Scott syndrome. Blood 1997; 89: 1599–1611
   PubMed Web of Science ®Google Scholar
• Banno Y, Nakashima S, Ohzawa M, Nozawa Y. Differential translocation of phospholipase C isozymes to integrin-mediated cytoskeletal complexes in thrombin-stimulated human platelets. J Biol Chem 1996; 271: 14989–14994
   PubMed Web of Science ®Google Scholar
• Miller G J. Lipoproteins and the haemostatic system in atherothrombotic disorders. Baillieres Clin Haematol 1994; 7: 713–732
   PubMedGoogle Scholar
• Esumi N, Todo S, Imashuku S. Platelet aggregating activity mediated by thrombin generation in the NCG human neuroblastoma cell line. Cancer Res 1987; 47: 2129–2135
   PubMed Web of Science ®Google Scholar
• Yoshida K, Kimura H. Presence of calmodulin in human platelet cytoskeletons and its concentration change upon activation of platelets. Biochim Biophys Acta 1984; 801: 290–297
   PubMedGoogle Scholar
• Sood R, Zogg M, Westrick R J, Guo Y H, Kerschen E J, Girardi G, Salmon J E, Coughlin S R, Weiler H. Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers. J Exp Med 2007; 204: 1049–1056
   PubMed Web of Science ®Google Scholar
• Hoffman M, Monroe D M, III. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958–965
   PubMed Web of Science ®Google Scholar
• Hung D T, Vu T K, Wheaton V I, Ishii K, Coughlin S R. Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest 1992; 89: 1350–1353
   PubMed Web of Science ®Google Scholar
• Wu C C, Teng C M. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation. Eur J Pharmacol 2006; 546: 142–147
   PubMed Web of Science ®Google Scholar
• Lisman T, Weeterings C, de Groot P G. Platelet aggregation: involvement of thrombin and fibrin(ogen). Front Biosci 2005; 10: 2504–2517
   PubMed Web of Science ®Google Scholar
• Keuren J F, Wielders S J, Ulrichts H, Hackeng T, Heemskerk J W, Deckmyn H, Bevers E M, Lindhout T. Synergistic effect of thrombin on collagen-induced platelet procoagulant activity is mediated through protease-activated receptor-1. Arterioscler Thromb Vasc Biol 2005; 25: 1499–1505
   PubMed Web of Science ®Google Scholar
• Lova P, Campus F, Lombardi R, Cattaneo M, Sinigaglia F, Balduini C, Torti M. Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the G(i)-independent activation of platelet Rap1B by thrombin. J Biol Chem 2004; 279: 25299–25306
   PubMed Web of Science ®Google Scholar
• Dubois C, Steiner B, Meyer Reigner S C. Contribution of PAR-1, PAR-4 and GPIbalpha in intracellular signaling leading to the cleavage of the beta3 cytoplasmic domain during thrombin-induced platelet aggregation. Thromb Haemost 2004; 91: 733–742
   PubMed Web of Science ®Google Scholar
• Soslau G, Class R, Morgan D A, Foster C, Lord S T, Marchese P, Ruggeri Z M. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 2001; 276: 21173–21183
   PubMed Web of Science ®Google Scholar
• Dicker I B, Pedicord D L, Seiffert D A, Jamieson G A, Greco N J. Both the high affinity thrombin receptor (GPIb-IX-V) and GPIIb/IIIa are implicated in expression of thrombin-induced platelet procoagulant activity. Thromb Haemost 2001; 86: 1065–1069
   PubMed Web of Science ®Google Scholar
• De Candia E, Hall S W, Rutella S, Landolfi R, Andrews R K, De C R. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets. J Biol Chem 2001; 276: 4692–4698
   PubMed Web of Science ®Google Scholar
• Monkovic D D, Tracy P B. Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990; 265: 17132–17140
   PubMed Web of Science ®Google Scholar
• Ahmad S S, Rawala-Sheikh R, Walsh P N. Comparative interactions of factor IX and factor IXa with human platelets. J Biol Chem 1989; 264: 3244–3251
   PubMed Web of Science ®Google Scholar
• Ahmad S S, Rawala-Sheikh R, Ashby B, Walsh P N. Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome. J Clin Invest 1989; 84: 824–828
   PubMed Web of Science ®Google Scholar
• Ahmad S S, Rawala-Sheikh R, Walsh P N. Platelet receptor occupancy with factor IXa promotes factor X activation. J Biol Chem 1989; 264: 20012–20016
   PubMed Web of Science ®Google Scholar
• Rawala-Sheikh R, Ahmad S S, Ashby B, Walsh P N. Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry 1990; 29: 2606–2611
   PubMed Web of Science ®Google Scholar
• Sinosich M J, Wolf J P, Williams R F, Hodgen G D. RU 486 mediated leukocytic inflammatory reaction at the utero-placental interface. Asia Oceania J Obstet Gynaecol 1989; 15: 375–381
   PubMedGoogle Scholar
• Richani K, Romero R, Soto E, Espinoza J, Nien J K, Chaiworapongsa T, Refuerzo J, Blackwell S, Edwin S S, Santolaya-Forgas J, et al. Unexplained intrauterine fetal death is accompanied by activation of complement. J Perinat Med 2005; 33: 296–305
   PubMed Web of Science ®Google Scholar
• Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin G. Am J Physiol 1990; 258: C1100–C1107
   PubMedGoogle Scholar
• Schjetlein R, Haugen G, Wisloff F. Markers of intravascular coagulation and fibrinolysis in preeclampsia: association with intrauterine growth retardation. Acta Obstet Gynecol Scand 1997; 76: 541–546
   PubMed Web of Science ®Google Scholar
• Sood R, Sholl L, Isermann B, Zogg M, Coughlin S R, Weiler H. Maternal Par4 and platelets contribute to defective placenta formation in mouse embryos lacking thrombomodulin. Blood 2008; 112: 585–591
   PubMed Web of Science ®Google Scholar
• Sood R, Kalloway S, Mast A E, Hillard C J, Weiler H. Fetomaternal cross talk in the placental vascular bed: control of coagulation by trophoblast cells. Blood 2006; 107: 3173–3180
   PubMed Web of Science ®Google Scholar
• Aharon A, Brenner B, Katz T, Miyagi Y, Lanir N. Tissue factor and tissue factor pathway inhibitor levels in trophoblast cells: implications for placental hemostasis. Thromb Haemost 2004; 92: 776–786
   PubMed Web of Science ®Google Scholar
• Isermann B, Sood R, Pawlinski R, Zogg M, Kalloway S, Degen J L, Mackman N, Weiler H. The thrombomodulin-protein C system is essential for the maintenance of pregnancy. Nat Med 2003; 9: 331–337
   PubMed Web of Science ®Google Scholar
• Lanir N, Aharon A, Brenner B. Procoagulant and anticoagulant mechanisms in human placenta. Semin Thromb Hemost 2003; 29: 175–184
   PubMed Web of Science ®Google Scholar
• Butenas S, Brummel-Ziedins K E, Mann K G. Real human tissue factor. FASEB J 2006; 20: A47
   Web of Science ®Google Scholar
• Butenas S, Orfeo T, Brummel-Ziedins K E, Mann K G. Tissue factor in thrombosis and hemorrhage. Surgery 2007; 142: S2–14
   PubMed Web of Science ®Google Scholar
• Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis 1995; 6(Suppl 1)S20–S25
   PubMed Web of Science ®Google Scholar
• Kobayashi M, Wada H, Wakita Y, Shimura M, Nakase T, Hiyoyama K, Nagaya S, Minami N, Nakano T, Shiku H. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura. Thromb Haemost 1995; 73: 10–14
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100: 2787–2792
   PubMed Web of Science ®Google Scholar
• Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex-vivo thrombi. Thromb Haemost 2002; 88: 822–826
   PubMed Web of Science ®Google Scholar
• Chou J, Mackman N, Merrill-Skoloff G, Pedersen B, Furie B C, Furie B. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 2004; 104: 3190–3197
   PubMed Web of Science ®Google Scholar
• Butenas S, Bouchard B A, Brummel-Ziedins K E, Parhami-Seren B, Mann K G. Tissue factor activity in whole blood. Blood 2005; 105: 2764–2770
   PubMed Web of Science ®Google Scholar
• Schneider C. The active principle of placental toxin:thromboplastin its inactivator in blood: antithromboplastin. Am J Physiol 1947; 149: 123
   PubMed Web of Science ®Google Scholar
• Erez O, Hoppensteadt D, Than N G, Fareed J, Mazaki-Tovi S, Espinoza J, Chaiworapongsa T, Yoon B H, Hassan S S, Gotsch F, et al. Tissue Factor and its Natural Inhibitor in Preeclampsia and SGA. J Matern Fetal Neonatal Med 2008; 12: 855–869
   Google Scholar
• Bellart J, Gilabert R, Angles A, Piera V, Miralles R M, Monasterio J, Cabero L. Tissue factor levels and high ratio of fibrinopeptide A:D-dimer as a measure of endothelial procoagulant disorder in pre-eclampsia. Br J Obstet Gynaecol 1999; 106: 594–597
   PubMedGoogle Scholar
• HOWIE B O. Intra-uterine foetal death with defective maternal blood-clotting mechanism. Proc R Soc Med 1956; 49: 93–96
   PubMedGoogle Scholar
• DeValera E. Abruptio placentae. Am J Obstet Gynecol 1968; 100: 599–606
   PubMed Web of Science ®Google Scholar
• Sher G, Statland B E. Abruptio placentae with coagulopathy: a rational basis for management. Clin Obstet Gynecol 1985; 28: 15–23
   PubMed Web of Science ®Google Scholar
• Oyelese Y, Ananth C V. Placental abruption. Obstet Gynecol 2006; 108: 1005–1016
   PubMed Web of Science ®Google Scholar
• Beller F K, Uszynski M. Disseminated intravascular coagulation in pregnancy. Clin Obstet Gynecol 1974; 17: 250–278
   PubMedGoogle Scholar
• Boulton F E, Letsky E. Obstetric haemorrhage: causes and management. Clin Haematol 1985; 14: 683–728
   PubMedGoogle Scholar
• Finley B E. Acute coagulopathy in pregnancy. Med Clin North Am 1989; 73: 723–743
   PubMed Web of Science ®Google Scholar
• Parasnis H, Raje B, Hinduja I N. Relevance of plasma fibrinogen estimation in obstetric complications. J Postgrad Med 1992; 38: 183–185
   PubMedGoogle Scholar
• Thomson A J, Greer I A. Non-haemorrhagic obstetric shock. Baillieres Best Pract Res Clin Obstet Gynaecol 2000; 14: 19–41
   PubMed Web of Science ®Google Scholar
• Awwad J T, Azar G B, Seoud M A, Mroueh A M, Karam K S. High-velocity penetrating wounds of the gravid uterus: review of 16 years of civil war. Obstet Gynecol 1994; 83: 259–264
   PubMed Web of Science ®Google Scholar
• Enakpene C A, Omigbodun A O, Arowojolu A O. Perinatal mortality following umbilical cord prolapse. Int J Gynaecol Obstet 2006; 95: 44–45
   PubMed Web of Science ®Google Scholar
• Aagaard-Tillery K M, Holmgren C, Lacoursiere D Y, Houssain S, Bloebaum L, Satterfield R, Branch D W, Varner M W. Factors associated with nonanomalous stillbirths: the Utah Stillbirth Database 1992–2002. Am J Obstet Gynecol 2006; 194: 849–854
   PubMed Web of Science ®Google Scholar
• Korteweg F J, Gordijn S J, Timmer A, Holm J P, Ravise J M, Erwich J J. A placental cause of intra-uterine fetal death depends on the perinatal mortality classification system used. Placenta 2008; 29: 71–80
   PubMed Web of Science ®Google Scholar
• Copper R L, Goldenberg R L, DuBard M B, Davis R O. Risk factors for fetal death in white, black, and Hispanic women. Collaborative Group on Preterm Birth Prevention. Obstet Gynecol 1994; 84: 490–495
   PubMed Web of Science ®Google Scholar
• Lammer E J, Brown L E, Anderka M T, Guyer B. Classification and analysis of fetal deaths in Massachusetts. JAMA 1989; 261: 1757–1762
   PubMed Web of Science ®Google Scholar
• Menghrajani P, Osterheld M C. Significance of hemorrhagic endovasculitis in placentae from stillbirths. Pathol Res Pract 2008; 204: 389–394
   PubMed Web of Science ®Google Scholar
• ACOG Committee Opinion No. 383. Evaluation of stillbirths and neonatal deaths. Obstet Gynecol 2007; 110: 963–966
   PubMedGoogle Scholar
• Corabian P, Scott N A, Lane C, Guyon G. Guidelines for investigating stillbirths: an update of a systematic review. J Obstet Gynaecol Can 2007; 29: 560–567
   PubMedGoogle Scholar
• Marchetti D, Belviso M, Marino M, Gaudio R. Evaluation of the placenta in a stillborn fetus to estimate the time of death. Am J Forensic Med Pathol 2007; 28: 38–43
   PubMed Web of Science ®Google Scholar
• Pasupathy D, Smith G C. The analysis of factors predicting antepartum stillbirth. Minerva Ginecol 2005; 57: 397–410
   PubMedGoogle Scholar
• Sander C M, Gilliland D, Richardson A, Foley K M, Fredericks J. Stillbirths with placental hemorrhagic endovasculitis: a morphologic assessment with clinical implications. Arch Pathol Lab Med 2005; 129: 632–638
   PubMed Web of Science ®Google Scholar
• Pierce B T, Martin L S, Hume R F, Jr., Calhoun B C, Muir-Padilla J, Salafia C M. Relationship between the extent of histologic villous mineralization and stillbirth in aneuploid and euploid fetuses. J Soc Gynecol Investig 2002; 9: 290–293
   PubMedGoogle Scholar
• Magee J F. Investigation of stillbirth. Pediatr Dev Pathol 2001; 4: 1–22
   PubMed Web of Science ®Google Scholar
• Kraus F T, Acheen V I. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol 1999; 30: 759–769
   PubMed Web of Science ®Google Scholar
• Incerpi M H, Miller D A, Samadi R, Settlage R H, Goodwin T M. Stillbirth evaluation: what tests are needed?. Am J Obstet Gynecol 1998; 178: 1121–1125
   PubMed Web of Science ®Google Scholar
• Adelson P, Spurrett B, Trudinger B, Frommer M. A New South Wales population-based study of stillbirths weighing 2,500 g or more. Aust N.Z J Obstet Gynaecol 1993; 33: 166–173
   PubMed Web of Science ®Google Scholar
• Gruenberger W, Gerstner G J. The causes of antepartum fetal death: a clinico-pathological study. Clin Exp Obstet Gynecol 1980; 7: 210–214
   PubMedGoogle Scholar
• Bendon R W. Review of some causes of stillbirth. Pediatr Dev Pathol 2001; 4: 517–531
   PubMed Web of Science ®Google Scholar
• Arias F, Romero R, Joist H, Kraus F T. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998; 7: 277–286
   PubMedGoogle Scholar
• Cartlidge P H, Dawson A T, Stewart J H, Vujanic G M. Value and quality of perinatal and infant postmortem examinations: cohort analysis of 400 consecutive deaths. BMJ 1995; 310: 155–158
   PubMed Web of Science ®Google Scholar
• Fretts R C, Boyd M E, Usher R H, Usher H A. The changing pattern of fetal death, 1961–1988. Obstet Gynecol 1992; 79: 35–39
   PubMed Web of Science ®Google Scholar
• Pauli R M, Reiser C A. Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first 1,000 referrals. Am J Med Genet 1994; 50: 135–153
   PubMed Web of Science ®Google Scholar
• Faye-Petersen O M, Guinn D A, Wenstrom K D. Value of perinatal autopsy. Obstet Gynecol 1999; 94: 915–920
   PubMed Web of Science ®Google Scholar
• Brummel K E, Paradis S G, Butenas S, Mann K G. Thrombin functions during tissue factor-induced blood coagulation. Blood 2002; 100: 148–152
   PubMed Web of Science ®Google Scholar